Picture of Cingulate logo

CING Cingulate Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Cingulate, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUS10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-11.5-7.18-20.7-17.7-23.5
Depreciation
Non-Cash Items-0.048012.80.8010.813
Other Non-Cash Items
Changes in Working Capital1.88-0.293-3.210.5997.1
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-9.53-6.81-10.4-15.9-15
Capital Expenditures-1.02-0.402-0.815-0.153-0.224
Purchase of Fixed Assets
Other Investing Cash Flow Items3.760.01800.001
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities2.74-0.384-0.815-0.153-0.224
Financing Cash Flow Items6.147.517.1-0.086
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities6.147.9726.54.99.95
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.6450.77915.3-11.1-5.3